Close Menu

The Scan

Kelvin Droegemeier, the director of the White House Office of Science and Technology Policy, is the new acting director of the US National Science Foundation.

Wired reports the University of California, Berkeley's Innovative Genomics Institute has transformed itself into a diagnostic lab to run SARS-CoV-2 tests.

Behind on Testing

An opinion piece at the Guardian discusses the state of SARS-CoV-2 testing in the UK.

In Nature this week: direct-capture Perturb-seq approach for combinatorial single-cell CRISPR screens, potential uses of genome-editing in breeding crops, and more.

The Atlantic reports another SARS-CoV-2 testing problem may be lurking: backlogs.

For a Vaccine

The US Biomedical Advanced Research and Development Authority is supporting efforts to develop vaccines against SARS-CoV-2.

The Sturgeon Genome

Researchers have sequenced the genome of "the Methuselah of freshwater fish."

In Genome Biology this week: difference in methylation in neurons from Parkinson's disease patients, differential expression analysis by barcoded sequencing approach, and more.

Finds a Whole Bunch

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Away From the Field

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

Relief Bill Signed

Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.

In a Different Lab

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

Little Bit Improved

A new analysis finds that peer review improves the quality of preprints just a little bit, according to ScienceInsider.

In PLOS this week: epigenetic drug triggers anti-viral activity, viral diversity among individuals with HIV experiencing virological failure, and more.

Extension Call

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

For the Accelerator

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

All Along the Axon

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.

The US Senate has unanimously passed a $2 trillion stimulus package to address the coronavirus, the New York Times reports.

The White House earlier this week announced a supercomputer consortium to uncover or develop drugs to address the COVID-19 pandemic, according to NPR.

The Next Test

The Los Angeles Times writes that another coronavirus testing challenge — antibody testing — looms. 

In Nature this week: single-cell transcriptomic data to map human tissue, combined genomic and machine learning approach for non-invasive early lung cancer screening, and more.

More Funds

The Washington Post reports the US Senate is to vote on a $2 trillion coronavirus stimulus package today.

Still Following It

Bloomberg writes that Fred Hutchinson Cancer Research Center's Trevor Bedford and his colleagues continue to use viral genomics to track SARS-CoV-2.

Pages

Kelvin Droegemeier, the director of the White House Office of Science and Technology Policy, is the new acting director of the US National Science Foundation.

An opinion piece at the Guardian discusses the state of SARS-CoV-2 testing in the UK.

Wired reports the University of California, Berkeley's Innovative Genomics Institute has transformed itself into a diagnostic lab to run SARS-CoV-2 tests.

In Nature this week: direct-capture Perturb-seq approach for combinatorial single-cell CRISPR screens, potential uses of genome-editing in breeding crops, and more.